KPV (Lysine-Proline-Valine)
KPV is the three-amino-acid tail of alpha-MSH: it keeps the parent hormone's anti-inflammatory power, drops the pigmentation, and targets inflamed tissue through the PepT1 transporter. The catch: every result so far is from cells or animals.
KPV (Lysine-Proline-Valine) is the C-terminal tripeptide of alpha-MSH, studied for anti-inflammatory, antimicrobial, gut, and skin applications. Evidence is entirely preclinical, with no completed human trials, and the compound is under FDA PCAC review for July 2026.
KPVpeptidesanti-inflammatoryalpha-MSHgut health+2